Columbia-based Ambu A/S, one of the fastest growing medical device companies and pioneer of sterile, single-use endoscopes, is receiving a Global New Product Innovation Award in the advanced visualization market from Frost & Sullivan, a global consulting firm.  

Frost & Sullivan selected Ambu due to its work in single-use flexible endoscopy, where Ambu is creating an innovation paradigm shift by rapidly bringing new technologies and products in shorter life cycles. That approach requires advanced modularization capabilities and promotes rapid adoption of new technologies and design improvements. 

Frost & Sullivan underlines how Ambu has successfully built a unique business model based on a visionary understanding of how endoscopy could be improved by leveraging new technology to better address patient needs. 

“Today, Ambu is the most innovative single-use endoscopy player in the market, with a commitment to be at the forefront of technology,” said Pavel Zhebrouski, Best Practices Research Analyst at Frost & Sullivan. “Frost & Sullivan feels that Ambu distinctly stands out in the market with its R&D and manufacturing engines outperforming competitors with its focus on innovation and high-scale, low-cost manufacturing.”  

Within bronchoscopy, 96% of the top 500 hospitals in the United States are using Ambu’s sterile, single-use bronchoscopes in the operating rooms and intensive care units.